Justin Chakma insider trades

Open-market stock purchases and sales by Justin Chakma, Chief Business Officer at ARS Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 8, 2022.

Recent trades

DateStockTradeValue
Jan 2, 2026SPRY ARS Pharmaceuticals, IncBought (not open market)—
Nov 12, 2025SPRY ARS Pharmaceuticals, IncSold$267K
Nov 12, 2025SPRY ARS Pharmaceuticals, IncSold$1.2M
Nov 12, 2025SPRY ARS Pharmaceuticals, IncBought (not open market)—

Companies traded

  • SPRY ARS Pharmaceuticals, Inc: 13 sales, last Jan 2, 2026

Get free alerts when Justin Chakma files a new trade →